Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Margaret C. Dunn"'
Autor:
Jitesh P. Jani, Gerrit Los, Kajiji Shama M, Bruce D. Cohen, Green Larry L, Kevin Coleman, Mary Campbell, Jinghai J. Xu, Elsa G. Barbacci-Tobin, Vahe Bedian, Konstantinos Tsaparikos, Jean-Martin Lapointe, Patrick Vincent, Boris A. Chrunyk, Neil R. Michaud, Stephen M. Hillerman, David F. Gebhard, Tim M. Coskran, George A. Karam, Margaret C. Dunn, Elisabeth Knauth, Stefan J. Steyn, Henry Putz, Gary Borzillo
Publikováno v:
mAbs. 4:710-723
The c-Met proto-oncogene is a multifunctional receptor tyrosine kinase that is stimulated by its ligand, hepatocyte growth factor (HGF), to induce cell growth, motility and morphogenesis. Dysregulation of c-Met function, through mutational activation
Publikováno v:
Combinatorial Chemistry & High Throughput Screening. 12:827-837
Efficiency and accuracy in addressing drug safety issues proactively are critical in minimizing late-stage drug attritions. Discovery Toxicology has become a specialty subdivision of Toxicology seeking to effectively provide early predictions and saf
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 795
Kinases are members of a major protein family targeted for drug discovery and development. Given the ubiquitous nature of many kinases as well as the broad range of pathways controlled by these enzymes, early safety assessments of small molecule inhi
Publikováno v:
Methods in Molecular Biology ISBN: 9781617793363
Kinases are members of a major protein family targeted for drug discovery and development. Given the ubiquitous nature of many kinases as well as the broad range of pathways controlled by these enzymes, early safety assessments of small molecule inhi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::305562501b8e54a4b2b1c226e40407c7
https://doi.org/10.1007/978-1-61779-337-0_6
https://doi.org/10.1007/978-1-61779-337-0_6
Autor:
Jinghai J. Xu, David B. Duignan, Vsevolod E. Kostrubsky, Margaret C. Dunn, Huifen F. Wang, Rouchelle J. Mireles, Ralph E. Davidson, Scott D. Campbell, Yi-an Bi, Arthur R. Smith, Bo Feng
Publikováno v:
Toxicological sciences : an official journal of the Society of Toxicology. 108(2)
CP-724,714, a potent and selective orally active HER2 tyrosine kinase inhibitor, was discontinued from clinical development due to unexpected hepatotoxicity in cancer patients. Based on the clinical manifestation of the toxicity, CP-724,714 likely ex
Autor:
David de Graaf, Peter V. Henstock, Arthur R. Smith, Jeffrey R. Chabot, Margaret C. Dunn, Jinghai J. Xu
Publikováno v:
Toxicological sciences : an official journal of the Society of Toxicology. 105(1)
Drug-induced liver injury (DILI) is the most common adverse event causing drug nonapprovals and drug withdrawals. Using drugs as test agents and measuring a panel of cellular phenotypes that are directly linked to key mechanisms of hepatotoxicity, we
Autor:
Sashi Nadanaciva, Arthur R. Smith, Lisa D. Marroquin, Margaret C. Dunn, James A. Dykens, Yvonne Will, Joseph D. Jamieson, Jinghai J. Xu
Publikováno v:
Toxicological sciences : an official journal of the Society of Toxicology. 103(2)
Mitochondrial toxicity is increasingly implicated in a host of drug-induced organ toxicities, including hepatotoxicity. Nefazodone was withdrawn from the U.S. market in 2004 due to hepatotoxicity. Accordingly, we evaluated nefazodone, another triazol
Autor:
Bo Feng, Jinghai J. Xu, Yi-An Bi, Rouchelle Mireles, Ralph Davidson, David B. Duignan, Scott Campbell, Vsevolod E. Kostrubsky, Margaret C. Dunn, Arthur R. Smith, Huifen F. Wang
Publikováno v:
Toxicological Sciences; Apr2009, Vol. 108 Issue 2, p492-500, 9p
Autor:
Jinghai J. Xu, Peter V. Henstock, Margaret C. Dunn, Arthur R. Smith, Jeffrey R. Chabot, David de Graaf
Publikováno v:
Toxicological Sciences; Sep2008, Vol. 105 Issue 1, p97-97, 1p
Autor:
James A. Dykens, Joseph D. Jamieson, Lisa D. Marroquin, Sashi Nadanaciva, Jinghai J. Xu, Margaret C. Dunn, Arthur R. Smith, Yvonne Will
Publikováno v:
Toxicological Sciences; Jun2008, Vol. 103 Issue 2, p335-335, 1p